Sepsivac Injection 0.6 ml

Sepsivac 0.6Ml Inj belongs to the group of medicines called immunotherapeutic agents used to treat leprosy. It is used to treat advanced non-small-cell lung cancer in combination with other medicines and as adjuvant therapy in sepsis. Leprosy is an infection caused by slow-growing bacteria called Mycobacterium leprae.

Sepsivac 0.6Ml Inj contains Mycobacterium W and Sodium chloride. Sepsivac 0.6Ml Inj works by altering the biological response or modifying the actions of the immune system of individuals to various pathological conditions.

Sepsivac 0.6Ml Inj should be administered by a healthcare professional. Do not self-administer. In some cases, you may experience some common side effects like injection site erythema (redness) and ulceration, nausea, vomiting, diarrhoea, pain, weakness and loss of appetite. Most of these side effects of Sepsivac 0.6Ml Inj do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, reach out to your doctor.

Consult your doctor if you are pregnant or breastfeeding. It is not known whether Sepsivac 0.6Ml Inj alters the ability to drive; do not drive or operate machinery if you experience any symptoms that affect your ability to concentrate and react. It is not known whether it is safe to consume alcohol with Sepsivac 0.6Ml Inj. However, as a precautionary measure, it is advisable not to take or limit alcohol.

Sepsivac 0.6Ml Inj is used in the treatment of leprosy, sepsis, and non-small cell lung cancer. The detailed uses of Sepsivac 0.6Ml Inj are as follows:

• Treatment of Leprosy: Sepsivac 0.6Ml Inj is used as an immunomodulator to treat leprosy by enhancing the body's immune response against Mycobacterium leprae, the responsible pathogen for the disease.
• Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC): Sepsivac 0.6Ml Inj is used in combination with other anticancer medications to treat advanced NSCLC by strengthening the immune response against cancer cells.
• Adjuvant Treatment in Sepsis: Sepsivac 0.6Ml Inj enhances the immune response in patients with sepsis, helping to reduce inflammation and control the infection when used alongside standard treatment.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Sepsivac 0.6Ml Inj will be administered by a medical professional.
• Do not self-administer.

Sepsivac 0.6Ml Inj belongs to the group of medicines called immunotherapeutic agents. It contains heat-killed strains of bacteria named 'Mycobacterium w' which is a non-pathogenic mycobacterium and has immunomodulatory properties. It is used as immunotherapy in leprosy, sepsis and in advanced non-small cell lung cancer along with other anti-cancer medicines. It works by altering the biological response of an individual to various pathological conditions.

Inform your doctor if you are allergic to any of the contents of Sepsivac 0.6Ml Inj, if you have a fever, generalised septic skin conditions, chronic debilitating conditions or any other health conditions. Consult your doctor if you are pregnant, planning for pregnancy or if you are breastfeeding. Keep your doctor informed about your health condition and all the medicines you take before taking Sepsivac 0.6Ml Inj to rule out any side effects.